JP2025510623A5 - - Google Patents
Info
- Publication number
- JP2025510623A5 JP2025510623A5 JP2024554796A JP2024554796A JP2025510623A5 JP 2025510623 A5 JP2025510623 A5 JP 2025510623A5 JP 2024554796 A JP2024554796 A JP 2024554796A JP 2024554796 A JP2024554796 A JP 2024554796A JP 2025510623 A5 JP2025510623 A5 JP 2025510623A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody conjugate
- conjugate according
- pharmaceutically acceptable
- antibody
- fuc
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP22163924.8 | 2022-03-23 | ||
| EP22163924 | 2022-03-23 | ||
| PCT/EP2023/057560 WO2023180484A1 (en) | 2022-03-23 | 2023-03-23 | Antibody-conjugates for targeting of tumours expressing ptk7 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2025510623A JP2025510623A (ja) | 2025-04-15 |
| JP2025510623A5 true JP2025510623A5 (cg-RX-API-DMAC10.html) | 2026-03-31 |
| JP7881734B2 JP7881734B2 (ja) | 2026-06-29 |
Family
ID=81308370
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024554796A Active JP7881734B2 (ja) | 2022-03-23 | 2023-03-23 | Ptk7を発現する腫瘍を標的化するための抗体コンジュゲート |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US12440573B2 (cg-RX-API-DMAC10.html) |
| EP (1) | EP4496592A1 (cg-RX-API-DMAC10.html) |
| JP (1) | JP7881734B2 (cg-RX-API-DMAC10.html) |
| KR (1) | KR20250024742A (cg-RX-API-DMAC10.html) |
| CN (1) | CN120826241A (cg-RX-API-DMAC10.html) |
| AU (1) | AU2023237619A1 (cg-RX-API-DMAC10.html) |
| CA (1) | CA3254479A1 (cg-RX-API-DMAC10.html) |
| IL (1) | IL315366A (cg-RX-API-DMAC10.html) |
| MX (1) | MX2024011518A (cg-RX-API-DMAC10.html) |
| WO (1) | WO2023180484A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3876998A1 (en) | 2018-11-05 | 2021-09-15 | Synaffix B.V. | Antibody-conjugates for targeting of tumours expressing trop-2 |
| JP2025533758A (ja) * | 2022-10-14 | 2025-10-09 | スーチュアン・コールン-バイオテック・バイオファーマシューティカル・カンパニー・リミテッド | 抗体-薬物複合体並びにその調製方法及び使用 |
| EP4737483A1 (en) * | 2023-06-30 | 2026-05-06 | Daiichi Sankyo Company, Limited | Antibody-drug conjugate production method including purification step using activated carbon material |
| EP4566631A1 (en) * | 2023-12-06 | 2025-06-11 | Heidelberg Pharma Research GmbH | New antibody drug conjugate as well as methods of production and uses thereof |
| CN121800878A (zh) * | 2025-12-30 | 2026-04-07 | 上海核舟医药有限公司 | Ptk7靶向药物及其制备方法和应用 |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4939255A (en) | 1987-06-24 | 1990-07-03 | Daiichi Pharmaceutical Co., Ltd. | Hexa-cyclic camptothecin derivatives |
| NZ569236A (en) | 2005-12-08 | 2012-06-29 | Medarex Inc | Human monoclonal antibodies to protein tyrosine kinase 7 (PTK7) and their use |
| US20070249014A1 (en) | 2006-02-10 | 2007-10-25 | Invitrogen Corporation | Labeling and detection of post translationally modified proteins |
| EP2229187A2 (en) * | 2007-11-30 | 2010-09-22 | Bristol-Myers Squibb Company | Monoclonal antibody partner molecule conjugates directed to protein tyrosine kinase 7 (ptk7) |
| US20090162359A1 (en) * | 2007-12-21 | 2009-06-25 | Christian Klein | Bivalent, bispecific antibodies |
| WO2009102820A2 (en) | 2008-02-11 | 2009-08-20 | Government Of The U.S A., As Represented By The Secretary, Department Of Health And Human Services | Modified sugar substrates and methods of use |
| HRP20180268T4 (hr) | 2012-10-23 | 2026-03-27 | Synaffix B.V. | Modificirano antitijelo, konjugat antitijela i postupak za njihovu pripremu |
| SG10201902571VA (en) | 2013-12-25 | 2019-04-29 | Daiichi Sankyo Co Ltd | Anti-trop2 antibody-drug conjugate |
| SMT202100146T1 (it) | 2014-04-30 | 2021-05-07 | Pfizer | Coniugati di anticorpo anti-ptk7-farmaco |
| EP3177633B1 (en) | 2014-08-04 | 2022-07-20 | SynAffix B.V. | Process for the modification of a glycoprotein using a beta-(1,4)-n-acetylgalactosaminyltransferase or a mutant thereof |
| EP3733209A1 (en) | 2014-10-03 | 2020-11-04 | Synaffix B.V. | Sulfamide linker, conjugates thereof, and methods of preparation |
| CN107810273B (zh) | 2015-04-23 | 2022-09-27 | 西纳福克斯股份有限公司 | 用为或衍生自β-(1,4)-N-乙酰半乳糖胺转移酶的糖基转移酶修饰糖蛋白的方法 |
| WO2017137457A1 (en) * | 2016-02-08 | 2017-08-17 | Synaffix B.V. | Antibody-conjugates with improved therapeutic index for targeting cd30 tumours and method for improving therapeutic index of antibody-conjugates |
| WO2017137456A1 (en) * | 2016-02-08 | 2017-08-17 | Synaffix B.V. | Bioconjugates containing sulfamide linkers for use in treatment |
| WO2017137458A1 (en) * | 2016-02-08 | 2017-08-17 | Synaffix B.V. | Antibody-conjugates with improved therapeutic index for targeting cd30 tumours and method for improving therapeutic index of antibody-conjugates |
| CA3026651A1 (en) | 2016-06-09 | 2017-12-14 | Blinkbio, Inc. | Silanol based therapeutic payloads |
| JP6888764B2 (ja) | 2016-12-29 | 2021-06-16 | ディヴェロップメント センター フォー バイオテクノロジー | 糖タンパク質−薬物コンジュゲートを調製する方法 |
| EP3720504A1 (en) | 2017-12-06 | 2020-10-14 | Synaffix B.V. | Enediyne conjugates |
| TWI920652B (zh) | 2018-06-07 | 2026-04-01 | 美商思進公司 | 喜樹鹼結合物 |
| EP3876998A1 (en) | 2018-11-05 | 2021-09-15 | Synaffix B.V. | Antibody-conjugates for targeting of tumours expressing trop-2 |
| US12146157B2 (en) * | 2018-11-07 | 2024-11-19 | Crispr Therapeutics Ag | Anti-PTK7 immune cell cancer therapy |
| KR20240104214A (ko) | 2019-03-29 | 2024-07-04 | 메디뮨 리미티드 | 화합물 및 이의 접합체 |
| RS64961B1 (sr) | 2019-04-26 | 2024-01-31 | Immunogen Inc | Derivati kamptotecina |
| KR20230021018A (ko) | 2020-06-05 | 2023-02-13 | 재단법인 생물기술개발중심 | 항-메조텔린 항체를 함유하는 항체-약물 컨쥬게이트 및 이의 용도 |
| NL2026400B1 (en) * | 2020-09-02 | 2022-05-04 | Synaffix Bv | Methods for the preparation of bioconjugates |
| JP7904824B2 (ja) | 2020-09-15 | 2026-08-13 | シンアフィックス ビー.ブイ. | 抗体-エクサテカンコンジュゲート |
| NL2026947B1 (en) | 2020-11-20 | 2022-07-01 | Synaffix Bv | Tyrosine-based antibody conjugates |
| CN113816969B (zh) | 2021-04-30 | 2024-01-16 | 联宁(苏州)生物制药有限公司 | 依喜替康类化合物、其抗体药物偶联物及其应用 |
| US12533419B2 (en) | 2021-07-19 | 2026-01-27 | Mabplex International Co., Ltd. | Antibody drug conjugate loaded with binary toxins and its application |
| MX2024011519A (es) | 2022-03-23 | 2024-09-24 | Synaffix Bv | Conjugados de anticuerpos para el direccionamiento contra tumores que expresan el antigeno carcinoembrionario. |
| CA3253220A1 (en) | 2022-03-23 | 2023-09-28 | Synaffix B.V. | ANTIBODIES CONJUGATED FOR TARGETING TUMORS EXPRESSING TROP-2 |
-
2023
- 2023-03-23 IL IL315366A patent/IL315366A/en unknown
- 2023-03-23 WO PCT/EP2023/057560 patent/WO2023180484A1/en not_active Ceased
- 2023-03-23 MX MX2024011518A patent/MX2024011518A/es unknown
- 2023-03-23 EP EP23713892.0A patent/EP4496592A1/en active Pending
- 2023-03-23 AU AU2023237619A patent/AU2023237619A1/en active Pending
- 2023-03-23 JP JP2024554796A patent/JP7881734B2/ja active Active
- 2023-03-23 CN CN202380028783.1A patent/CN120826241A/zh active Pending
- 2023-03-23 KR KR1020247034724A patent/KR20250024742A/ko active Pending
- 2023-03-23 CA CA3254479A patent/CA3254479A1/en active Pending
-
2024
- 2024-09-20 US US18/892,253 patent/US12440573B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025510678A5 (cg-RX-API-DMAC10.html) | ||
| JP2020189977A5 (cg-RX-API-DMAC10.html) | ||
| JP6733993B2 (ja) | スルファミドリンカー、スルファミドリンカーのコンジュゲート、及び調製の方法 | |
| US6573245B1 (en) | Modified polysaccharide adjuvant-protein antigen conjugates, the preparation thereof and the use thereof | |
| US6960344B2 (en) | Use of imine-forming polysaccharides as adjuvants and immunostimulants | |
| JP2020000252A5 (cg-RX-API-DMAC10.html) | ||
| EP0180564B1 (en) | Immunogenic complex, a method for producing the same, and the use thereof as an immune stimulant, vaccines and reagents | |
| AU2007343610B2 (en) | Polymeric carriers of therapeutic agents and recognition moieties for antibody-based targeting of disease sites | |
| Ni et al. | Toward a carbohydrate-based HIV-1 vaccine: synthesis and immunological studies of oligomannose-containing glycoconjugates | |
| US6071532A (en) | Synthesis of glycophospholipid and peptide-phospholipid conjugates and uses thereof | |
| NZ755831A (en) | Polypeptide-antigen conjugates with non-natural amino acids | |
| CN1596129A (zh) | 多糖结合物形式的含有氨基糖的水溶性抗生素 | |
| JPWO2021049504A5 (cg-RX-API-DMAC10.html) | ||
| JP2005530493A5 (cg-RX-API-DMAC10.html) | ||
| JP2024544959A5 (cg-RX-API-DMAC10.html) | ||
| JP2908558B2 (ja) | 炭水化物のアクリル及びメタクリルコポリマー並びに該ポリマーの製造方法 | |
| JP2025510700A5 (cg-RX-API-DMAC10.html) | ||
| Warren et al. | Synthetic glycopeptide-based vaccines | |
| ES2338558T3 (es) | Nuevos derivados de ciclodextrinas, su procedimiento de preparacion y su utilizacion en particular para la solubilizacion de sustancias farmacologicamente activas. | |
| KR890016059A (ko) | 포스포노알킬퓨린 유도체 | |
| CA2376164A1 (en) | Intermolecularly associating compounds, and aggregates comprising them | |
| JP2013505302A (ja) | イヌリンの新たな多形形態エプシロン・イヌリンおよびその組成物 | |
| CA2354928A1 (en) | Non-mucin type synthetic compounds or it's carrier conjugated compounds | |
| EP2890703B1 (en) | Synthesis of diverse glycosylphosphatidylinositol glycans from toxoplasma gondii and their application as vaccines and diagnostics | |
| JP2001503437A (ja) | 1―チオガラクトース誘導体 |